unknown
Stage
About
Curza is a therapeutics company developing novel small-molecule antibiotics targeting drug-resistant bacterial infections, including ESKAPE pathogens and biofilm-related infections.
Explore Curza's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.